Birdwatch Archive

Birdwatch Note

2024-12-04 14:56:20 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

筋萎縮性側索硬化症(ALS)の各年度末の特定医療費(指定難病)受給者証所持者数推移は下記の通りで、ワクチンにせよ、何のせいにせよ目立った動態変化は確認できませんので誤解を招く投稿としてノートを記載します。 https://www.nanbyou.or.jp/entry/5354 H28年度末:9557 H29年度末:9636 H30年度末:9805 R1年度末:9894 R2年度末:10514 R3年度末:9968 R4年度末:9765 R5年度末:9727

Written by F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1864244158527099012

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1864322852423651534
  • noteId - 1864322852423651534
  • participantId -
  • noteAuthorParticipantId - F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D Participant Details
  • createdAtMillis - 1733324180119
  • tweetId - 1864244158527099012
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 1
  • misleadingManipulatedMedia - 1
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 1
  • misleadingUnverifiedClaimAsFact - 1
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • 筋萎縮性側索硬化症(ALS)の各年度末の特定医療費(指定難病)受給者証所持者数推移は下記の通りで、ワクチンにせよ、何のせいにせよ目立った動態変化は確認できませんので誤解を招く投稿としてノートを記載します。 https://www.nanbyou.or.jp/entry/5354 H28年度末:9557 H29年度末:9636 H30年度末:9805 R1年度末:9894 R2年度末:10514 R3年度末:9968 R4年度末:9765 R5年度末:9727

Note Ratings

rated at rated by
2024-12-04 17:26:26 -0600 Rating Details
2024-12-04 10:17:40 -0600 Rating Details
2024-12-04 09:00:34 -0600 Rating Details
2024-12-04 08:58:26 -0600 Rating Details